Join Slalom, AWS, NDA Partners, and your executive peers in a thought-provoking discussion about the future of AI and GenAI in Life Sciences as it relates to regulatory, government affairs, and policy.

We expect topics ranging from:

• Accelerating science to market across drug, device, or digital Tx development with AI regulatory in mind from the start
• Enabling real patient and commercial impact while mitigating compliance and regulatory risk
• Innovating with and influencing regulatory policy
• Future of regulatory and government affairs

Come enjoy drinks, appetizers and a lively conversation!

Location: Shack 15, private space in the iconic Ferry Building

Date: Thursday, November 16th

Time: 4:00pm - 6:00pm; casual networking following

Style: Jeffersonian Roundtable w/ peers & experts under Chatham House Rules

Read perspectives captured from previous AI roundtables here: Unlocking the Future of Life Sciences R&D part 1, part 2, and part 3.

Joining from NDA Partners (a ProPharma Company), will be Eric Fish, VP and General Manager and Brendan O’Leary, Digital Health Expert and Consultant. 

ProPharma offers an end-to-end suite of fully customizable consulting solutions that de-risk and accelerate our partners’ most high-profile drug and device programs. As the world’s largest RCO (Research Consulting Organization), ProPharma partners with its clients through an advise-build-operate model across the complete product lifecycle. With deep domain expertise in regulatory sciences, clinical research solutions, quality and compliance, pharmacovigilance, medical information, and R&D technology.